David joined Grund IP Group in 2020 as a patent attorney candidate, where he is gaining practical, hands-on experience in a wide variety of intellectual property matters including the drafting, prosecution, and defense of European and international (PCT) patents, EU trademark and design applications and patents, and preparing submissions for both opposition proceedings and appeal hearings before the European Patent Office. His technical focus is on inventions originating from the technical areas of molecular biology, oncology, genetics, immunology, virology, microbiology, biochemical techniques and diagnostics, pharmaceutical sciences, and related medical devices in the mechanical arts.
Prior to pursuing a career in intellectual property, David completed his undergraduate degree in Biology with an emphasis on cellular and molecular biology at the University of Lethbridge, Canada, where he was awarded the Jason Lang Scholarship for outstanding academic achievement. He continued his studies at the University of Lethbridge and completed a Master’s thesis in the laboratory of Prof. Dr. Olga Kovalchuk. During this time, his research focused on the epigenetic mechanisms involved in circadian disruption-induced breast cancer for which he was awarded the Alberta Graduate Student Scholarship for academic excellence. David was then accepted into the PhD programme at the Cologne Graduate School of Aging Research in Cologne, Germany where he received a fully funded PhD research fellowship. In parallel to the PhD programme, he completed his PhD thesis in the laboratory of Dr. Peter Tessarz at the Max Planck Institute for Biology of Aging, where his research focused on the identification of a novel, context-dependent, post-transcriptional mRNA buffering system triggered by chromatin deregulation.